bayesian multiclass models (Novartis)
90
Structured Review
Novartis
bayesian multiclass models
Bayesian Multiclass Models, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+multiclass+models/bayesian+logistic+regression+model/pm24575966-187-2-7
Average 90 stars, based on 1 article reviews
Bayesian Multiclass Models, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+multiclass+models/bayesian+logistic+regression+model/pm24575966-187-2-7
Average 90 stars, based on 1 article reviews
bayesian multiclass models - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
In Silico:Article Title: Predictive in silico off-target profiling in drug discovery. Article Snippet: In the past, pharmaceutical drug discovery was focused on the design and development of smallmolecule drugs typically highly active against a single desired biological target or mechanism.. Following the advent of miniaturized in vitro screening technologies, the promiscuity of many small molecules was unveiled by the discovery of a multitude of biologically relevant interactions.. In addition to purposely designed ‘ontarget’ affinity essential for treating a pathological condition in vivo, binding also occurs to multiple ‘off-targets’ [1], which are sometimes highly unrelated in molecular structure to the primary target, function or phylogenesis, and can thus account for substantially different effects in vivo. |